Income Statement Seelos Therapeutics, Inc.

Stocks

SEEL.Q

US81577F4063

Biotechnology & Medical Research

Market Closed - OTC Markets 09:55:32 01/06/2026 pm IST			5-day change	1st Jan Change
0.000100 ^USD	+9,900.00%		-.--%	+9,900.00%

29/12	Motion for Asset Sale Approved for Seelos Therapeutics, Inc.	CI
21/25/21	GLD Partners, LP acquired Select assets from Seelos Therapeutics, Inc. (OTCPK : SEEL.Q).	CI

307ffc561ef.arXiJn2GoNSxCYAUCZA6IBDtw4V-LObJSljnpE_fhfU.U4aNTTzT6bDUZ7YkUcUDFCDctrwJTZSxBWyqnCezw8MZwrNsUPHi4fBv4w

Published financial data: SEELOS THERAPEUTICS, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019 (USD)	2020 (USD)	2021 (USD)	2022 (USD)	2023 (USD)
Revenues	4L	-	-	-	22.03L
Total Revenues	4L	-	-	-	22.03L
Cost of Goods Sold, Total	-	1.1Cr	-	-	3.01Cr
Gross Profit	4L	-1.1Cr	-	-	-2.79Cr
Selling General & Admin Expenses, Total	55.59L	77.75L	1.5Cr	1.23Cr	1.26Cr
R&D Expenses	2.26Cr	-	4.66Cr	5.86Cr	-
Other Operating Expenses	-	-	-	-	-
Other Operating Expenses, Total	2.81Cr	77.75L	6.17Cr	7.09Cr	1.26Cr
Operating Income	-2.77Cr	-1.88Cr	-6.17Cr	-7.09Cr	-4.05Cr
Interest Expense, Total	-29T	-2L	-15.98L	-14T	-75T
Interest And Investment Income	2L	45T	1L	1L	2L
Net Interest Expenses	1L	-1L	-14.85L	1L	1L
Other Non Operating Income (Expenses)	-2.15Cr	-2L	-9L	3L	1.37Cr
EBT, Excl. Unusual Items	-4.91Cr	-1.91Cr	-6.4Cr	-7.05Cr	-2.67Cr
Merger & Related Restructuring Charges	-20L	-	-	-	-
Other Unusual Items	-1L	-	-20.08L	-30.17L	-1.12Cr
EBT, Incl. Unusual Items	-5.13Cr	-1.91Cr	-6.6Cr	-7.35Cr	-3.79Cr
Earnings From Continuing Operations	-5.13Cr	-1.91Cr	-6.6Cr	-7.35Cr	-3.79Cr
Earnings Of Discontinued Operations	-	-	-	-	-
Net Income to Company	-5.13Cr	-1.91Cr	-6.6Cr	-7.35Cr	-3.79Cr
Net Income - (IS)	-5.13Cr	-1.91Cr	-6.6Cr	-7.35Cr	-3.79Cr
Net Income to Common Incl Extra Items	-5.13Cr	-1.91Cr	-6.6Cr	-7.35Cr	-3.79Cr
Net Income to Common Excl. Extra Items	-5.13Cr	-1.91Cr	-6.6Cr	-7.35Cr	-3.79Cr
Per Share Items
Net EPS - Basic	-	-1.64T	-2.79T	-2.66T	-989.53
Basic EPS - Continuing Operations	-	-1.64T	-2.79T	-2.66T	-989.53
Basic Weighted Average Shares Outstanding	-	11.66T	23.67T	27.69T	38.28T
Net EPS - Diluted	-	-1.64T	-2.79T	-2.66T	-989.53
Diluted EPS - Continuing Operations	-	-1.64T	-2.79T	-2.66T	-989.53
Diluted Weighted Average Shares Outstanding	-	11.66T	23.67T	27.69T	38.28T
Normalized Basic EPS	-	-1.02T	-1.69T	-1.59T	-435.6
Normalized Diluted EPS	-	-1.02T	-1.69T	-1.59T	-435.6
Supplemental Items
EBITDA	-2.77Cr	-	-	-	-
EBITA	-2.77Cr	-1.88Cr	-6.17Cr	-7.09Cr	-4.05Cr
EBIT	-2.77Cr	-1.88Cr	-6.17Cr	-7.09Cr	-4.05Cr
EBITDAR	-2.76Cr	-	-	-	-
Total Revenues (As Reported)	4L	-	-	-	22.03L
Normalized Net Income	-3.07Cr	-1.19Cr	-4Cr	-4.41Cr	-1.67Cr
Interest on Long-Term Debt	-	-	15.98L	14T	75T
Supplemental Operating Expense Items
General and Administrative Expenses	55.59L	77.75L	1.5Cr	1.23Cr	1.26Cr
Research And Development Expense From Footnotes	2.26Cr	1.1Cr	4.66Cr	5.86Cr	3.01Cr
Net Rental Expense, Total	1L	1L	1L	1L	1L
Imputed Operating Lease Interest Expense	-	-	89.14T	573	3.49T
Imputed Operating Lease Depreciation	-	-	10.86T	99.43T	96.51T
Stock-Based Comp., COGS (Total)	-	4L	7L	-	10.37L
Stock-Based Comp., R&D Exp. (Total)	1L	-	-	9L	-
Stock-Based Comp., G&A Exp. (Total)	3L	16.5L	76.3L	41.41L	29.51L
Stock-Based Comp., Other (Total)	-	1L	-	-	-
Total Stock-Based Compensation	5L	21.68L	83.47L	50.73L	39.88L

Fiscal Period: December	2019 (USD)	2020 (USD)	2021 (USD)	2022 (USD)	2023 (USD)
Assets
Cash And Equivalents	1.03Cr	1.57Cr	7.87Cr	1.55Cr	29.96L
Total Cash And Short Term Investments	1.03Cr	1.57Cr	7.87Cr	1.55Cr	29.96L
Accounts Receivable, Total	-	-	-	-	8L
Total Receivables	-	-	-	-	8L
Prepaid Expenses	8L	18.32L	45.4L	69.41L	15.67L
Other Current Assets, Total	-	-	2L	2L	77T
Total Current Assets	1.11Cr	1.75Cr	8.35Cr	2.27Cr	54.03L
Gross Property Plant And Equipment	-	-	-	-	-
Accumulated Depreciation	-	-	-	-	-
Net Property Plant And Equipment	-	-	39T	72T	15T
Other Long-Term Assets, Total	-	-	-	-	-
Total Assets	1.11Cr	1.75Cr	8.35Cr	2.27Cr	54.18L
Liabilities
Accounts Payable, Total	8L	18.87L	16.93L	36.26L	1.64Cr
Accrued Expenses, Total	19.19L	19.24L	37.28L	72.82L	25.16L
Current Portion of Long-Term Debt	-	24.31L	10.3L	1.19Cr	1.42Cr
Current Portion of Leases	-	-	38T	58T	15T
Other Current Liabilities	80.63L	11.87L	17.98L	23.27L	57.81L
Total Current Liabilities	1.08Cr	74.29L	82.87L	2.52Cr	3.89Cr
Long-Term Debt	-	72.93L	1.79Cr	81.84L	-
Long-Term Leases	-	-	-	15T	-
Other Non Current Liabilities	3L	2L	-	-	-
Total Liabilities	1.11Cr	1.49Cr	2.62Cr	3.34Cr	3.89Cr
Common Stock, Total	27T	54T	1L	1L	10T
Additional Paid In Capital	5.6Cr	7.77Cr	20Cr	20Cr	22Cr
Retained Earnings	-5.61Cr	-7.52Cr	-14Cr	-21Cr	-25Cr
Total Common Equity	-7T	25.72L	5.73Cr	-1.06Cr	-3.35Cr
Total Equity	-7T	25.72L	5.73Cr	-1.06Cr	-3.35Cr
Total Liabilities And Equity	1.11Cr	1.75Cr	8.35Cr	2.27Cr	54.18L
Supplemental Items
ECS Total Shares Outstanding on Filing Date	9.51T	19.08T	27.48T	28.15T	1L
ECS Total Common Shares Outstanding	7.04T	14.2T	27.47T	27.91T	76.52T
Book Value / Share	-0.99	181.1	2.09T	-380.21	-437.92
Tangible Book Value	-7T	25.72L	5.73Cr	-1.06Cr	-3.35Cr
Tangible Book Value Per Share	-0.99	181.1	2.09T	-380.21	-437.92
Total Debt	0	97.24L	1.9Cr	2.01Cr	1.42Cr
Net Debt	-1.03Cr	-59.38L	-5.98Cr	45.89L	1.12Cr
Debt Equivalent Oper. Leases	8L	8L	8L	8L	8L
Account Code - Inventory Valuation	3	3	3	3	3
Machinery, Total	-	-	-	-	-
Full Time Employees	6	9	15	15	15
Part Time Employees	-	1	1	1	1
Assets under Capital Lease - Gross	-	-	-	-	-

Fiscal Period: December	2019 (USD)	2020 (USD)	2021 (USD)	2022 (USD)	2023 (USD)
Net Income	-5.13Cr	-1.91Cr	-6.6Cr	-7.35Cr	-3.79Cr
Depreciation & Amortization - CF	-	-	-	53T	57T
Depreciation & Amortization, Total	-	-	-	53T	57T
Amortization of Deferred Charges, Total - (CF)	-	2L	15.82L	-	-
Asset Writedown & Restructuring Costs	30L	2L	56.37L	12.96L	-
Stock-Based Compensation (CF)	5L	21.68L	83.47L	50.73L	39.88L
Net Cash From Discontinued Operations	-	-	-	-	-
Other Operating Activities, Total	2.16Cr	2L	28.94L	27.25L	-24.94L
Change In Accounts Payable	-14.24L	10.91L	-2L	19.33L	1.28Cr
Change in Unearned Revenues	-	-	-	-	-
Change in Other Net Operating Assets	82.85L	-56.36L	-12.13L	8L	-4L
Cash from Operations	-1.93Cr	-2.09Cr	-4.9Cr	-6.16Cr	-2.39Cr
Sale (Purchase) of Intangible assets	-	-	-	-	-
Cash from Investing	-	-	-	-	-
Long-Term Debt Issued, Total	-	1L	-	-	-
Total Debt Issued	-	1L	-	-	-
Long-Term Debt Repaid, Total	-	-	-1.36Cr	-18.88L	-76.41L
Total Debt Repaid	-	-	-1.36Cr	-18.88L	-76.41L
Issuance of Common Stock	1.3Cr	2.62Cr	13Cr	6L	2.02Cr
Repurchase of Common Stock	-	-	-	-	-11.95L
Other Financing Activities, Total	1.65Cr	-	-	-3L	-
Cash from Financing	2.95Cr	2.63Cr	11Cr	-15.97L	1.14Cr
Net Change in Cash	1.02Cr	54.01L	6.31Cr	-6.32Cr	-1.25Cr
Supplemental Items
Cash Interest Paid	16T	11T	10T	11T	5L
Levered Free Cash Flow	-92.64L	-1.63Cr	-3.03Cr	-3.56Cr	-51.15L
Unlevered Free Cash Flow	-92.46L	-1.63Cr	-3.09Cr	-3.56Cr	-50.68L
Change In Net Working Capital	-76.37L	67.77L	7L	-36.02L	-1.62Cr
Net Debt Issued / Repaid	-	1L	-1.36Cr	-18.88L	-76.41L

Fiscal Period: December	2019 (USD)	2020 (USD)	2021 (USD)	2022 (USD)	2023 (USD)
Profitability
Return on Assets	-307.29	-82.02	-76.33	-83.43	-179.75
Return on Total Capital	1.53T	-190.81	-87.03	-103.33	518.1
Return On Equity %	2.18T	-1.49T	-220.55	-314.84	171.72
Return on Common Equity	2.18T	-1.49T	-220.55	-314.84	171.72
Margin Analysis
Gross Profit Margin %	100	-	-	-	-1.27T
SG&A Margin	1.48T	-	-	-	571.27
EBITDA Margin %	-7.39T	-	-	-	-
EBITA Margin %	-7.4T	-	-	-	-1.84T
EBIT Margin %	-7.4T	-	-	-	-1.84T
Income From Continuing Operations Margin %	-13.67T	-	-	-	-1.72T
Net Income Margin %	-13.67T	-	-	-	-1.72T
Net Avail. For Common Margin %	-13.67T	-	-	-	-1.72T
Normalized Net Income Margin	-8.19T	-	-	-	-756.98
Levered Free Cash Flow Margin	-2.47T	-	-	-	-232.17
Unlevered Free Cash Flow Margin	-2.47T	-	-	-	-230.04
Asset Turnover
Asset Turnover	0.07	-	-	-	0.16
Fixed Assets Turnover	-	-	-	-	50.64
Short Term Liquidity
Current Ratio	1.03	2.35	10.07	0.9	0.14
Quick Ratio	0.95	2.11	9.5	0.62	0.1
Operating Cash Flow to Current Liabilities	-1.79	-2.82	-5.91	-2.45	-0.61
Average Days Payable Outstanding	-	44.7	-	-	121.37
Long Term Solvency
Total Debt/Equity	-	378.07	33.07	-189.63	-42.46
Total Debt / Total Capital	-	79.08	24.85	211.57	-73.79
LT Debt/Equity	-	283.55	31.21	-77.27	-
Long-Term Debt / Total Capital	-	59.31	23.45	86.21	-
Total Liabilities / Total Assets	100.06	85.3	31.35	146.65	718.49
EBIT / Interest Expense	-956.79	-114.38	-38.59	-5.07T	-539.99
EBITDA / Interest Expense	-955.38	-	-38.53	-5.06T	-538.65
(EBITDA - Capex) / Interest Expense	-955.38	-	-38.53	-5.06T	-538.65
Total Debt / EBITDA	-	-	-0.31	-0.28	-0.35
Net Debt / EBITDA	0.37	-	0.97	-0.06	-0.28
Total Debt / (EBITDA - Capex)	-	-	-0.31	-0.28	-0.35
Net Debt / (EBITDA - Capex)	0.37	-	0.97	-0.06	-0.28
Growth Over Prior Year
Gross Profit, 1 Yr. Growth %	-	-50.5	-	-	-52.38
EBITDA, 1 Yr. Growth %	781.51	-	-	-	-
EBITA, 1 Yr. Growth %	771.45	-32.39	228.74	14.99	-42.89
EBIT, 1 Yr. Growth %	771.45	-32.39	228.74	14.99	-42.89
Earnings From Cont. Operations, 1 Yr. Growth %	1.37T	-62.73	245.78	11.33	-48.48
Net Income, 1 Yr. Growth %	1.37T	-62.73	245.78	11.33	-48.48
Normalized Net Income, 1 Yr. Growth %	1.38T	-61.13	235.27	10.11	-62.16
Diluted EPS Before Extra, 1 Yr. Growth %	-	-	70.31	-4.84	-62.73
Net Property, Plant and Equip., 1 Yr. Growth %	-	-	-	84.62	-79.17
Total Assets, 1 Yr. Growth %	5.71T	57.66	377.31	-72.76	-76.18
Tangible Book Value, 1 Yr. Growth %	-99.85	-36.84T	2.13T	-118.51	215.8
Common Equity, 1 Yr. Growth %	-99.85	-36.84T	2.13T	-118.51	215.8
Cash From Operations, 1 Yr. Growth %	1.12T	8.33	134.28	25.74	-61.18
Levered Free Cash Flow, 1 Yr. Growth %	778.21	75.8	85.97	17.55	-85.63
Unlevered Free Cash Flow, 1 Yr. Growth %	850.24	76.66	89	15.3	-85.76
Compound Annual Growth Rate Over Two Years
EBITDA, 2 Yr. CAGR %	62.01	-	-	-	-
EBITA, 2 Yr. CAGR %	61.24	142.73	49.08	94.43	-18.96
EBIT, 2 Yr. CAGR %	61.24	142.73	49.08	94.43	-18.96
Earnings From Cont. Operations, 2 Yr. CAGR %	108.87	134.45	13.52	96.21	-24.27
Net Income, 2 Yr. CAGR %	1.16T	134.45	13.52	96.21	-24.27
Normalized Net Income, 2 Yr. CAGR %	108.32	140.04	14.15	92.14	-35.45
Diluted EPS Before Extra, 2 Yr. CAGR %	-	-	-	27.3	-40.45
Net Property, Plant and Equip., 2 Yr. CAGR %	-	-	-	-	-37.98
Total Assets, 2 Yr. CAGR %	28.63	857.04	174.32	14.03	-74.53
Tangible Book Value, 2 Yr. CAGR %	-96	-26.07	8.95T	103.12	-23.54
Common Equity, 2 Yr. CAGR %	-96	-26.07	8.95T	103.12	-23.54
Cash From Operations, 2 Yr. CAGR %	35.81	263.7	59.31	71.63	-30.14
Levered Free Cash Flow, 2 Yr. CAGR %	-	292.92	80.81	47.86	-58.91
Unlevered Free Cash Flow, 2 Yr. CAGR %	-	309.71	82.72	47.62	-59.48
Compound Annual Growth Rate Over Three Years
EBITA, 3 Yr. CAGR %	298.9	20.68	168.55	36.72	29.24
EBIT, 3 Yr. CAGR %	298.9	20.68	168.55	36.72	29.24
Earnings From Cont. Operations, 3 Yr. CAGR %	389.45	17.58	166.87	12.78	25.64
Net Income, 3 Yr. CAGR %	389.45	290.41	166.87	12.78	25.64
Normalized Net Income, 3 Yr. CAGR %	382.64	19.03	168.32	12.79	11.79
Diluted EPS Before Extra, 3 Yr. CAGR %	-	-	-	-	-15.47
Total Assets, 3 Yr. CAGR %	-	37.66	658.96	27.03	-32.34
Tangible Book Value, 3 Yr. CAGR %	-69.79	-16.2	130.09	1.05T	135.31
Common Equity, 3 Yr. CAGR %	-69.79	-16.2	130.09	1.05T	135.31
Cash From Operations, 3 Yr. CAGR %	-	25.95	214.1	47.22	4.57
Levered Free Cash Flow, 3 Yr. CAGR %	-	-	206.21	56.64	-32.03
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	-	216.57	56.73	-32.3
Compound Annual Growth Rate Over Five Years
EBITA, 5 Yr. CAGR %	-	-	169.08	46.05	66.3
EBIT, 5 Yr. CAGR %	-	-	169.08	46.05	66.3
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	172.8	44.31	61.25
Net Income, 5 Yr. CAGR %	-	-	172.8	196.48	61.25
Normalized Net Income, 5 Yr. CAGR %	-	-	171.12	44.16	51.76
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	-	-1.84	-
Total Assets, 5 Yr. CAGR %	-	-	-	27.67	95.24
Tangible Book Value, 5 Yr. CAGR %	-	-	195.6	19.41	48.08
Common Equity, 5 Yr. CAGR %	-	-	195.6	19.41	48.08
Cash From Operations, 5 Yr. CAGR %	-	-	-	42.55	72.16
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	37.13
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	-	39.1